Janet C. Reid

417 total citations
16 papers, 327 citations indexed

About

Janet C. Reid is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Janet C. Reid has authored 16 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Janet C. Reid's work include Peptidase Inhibition and Analysis (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Janet C. Reid is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Janet C. Reid collaborates with scholars based in Australia, United States and Ireland. Janet C. Reid's co-authors include John D. Hooper, Matthew A. Cooper, Mark N. Adams, Emma Frow, Michelle Rourke, Claudia E. Vickers, Maciej B. Holowko, Avril A. B. Robertson, Judith A. Clements and Ruby Pelingon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Materials Chemistry B.

In The Last Decade

Janet C. Reid

14 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet C. Reid Australia 9 189 62 42 39 36 16 327
Byung Soo Kim South Korea 10 177 0.9× 164 2.6× 58 1.4× 35 0.9× 75 2.1× 24 413
Costakis Frangou United States 7 165 0.9× 74 1.2× 45 1.1× 37 0.9× 56 1.6× 7 443
Kyeongmin Kim South Korea 10 187 1.0× 90 1.5× 93 2.2× 25 0.6× 14 0.4× 33 454
Jae Hoo Park South Korea 9 145 0.8× 81 1.3× 30 0.7× 19 0.5× 61 1.7× 20 286
Timothy S. Collins United States 9 252 1.3× 146 2.4× 68 1.6× 26 0.7× 37 1.0× 10 461
Jennifer Reid Canada 8 257 1.4× 65 1.0× 57 1.4× 51 1.3× 212 5.9× 20 468
Elke Malenke Germany 9 126 0.7× 82 1.3× 22 0.5× 16 0.4× 30 0.8× 13 303
Jennifer N. Saultz United States 9 247 1.3× 101 1.6× 61 1.5× 69 1.8× 263 7.3× 31 506
André Roy Canada 11 265 1.4× 138 2.2× 16 0.4× 15 0.4× 31 0.9× 22 495
Michael Leisch Austria 9 115 0.6× 72 1.2× 56 1.3× 54 1.4× 78 2.2× 14 273

Countries citing papers authored by Janet C. Reid

Since Specialization
Citations

This map shows the geographic impact of Janet C. Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet C. Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet C. Reid more than expected).

Fields of papers citing papers by Janet C. Reid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet C. Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet C. Reid. The network helps show where Janet C. Reid may publish in the future.

Co-authorship network of co-authors of Janet C. Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Janet C. Reid. A scholar is included among the top collaborators of Janet C. Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet C. Reid. Janet C. Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Holowko, Maciej B., Emma Frow, Janet C. Reid, Michelle Rourke, & Claudia E. Vickers. (2020). Building a biofoundry. PubMed. 6(1). ysaa026–ysaa026. 49 indexed citations
2.
Wei, Ang Chee, Lendl Tan, Melissa L. Sykes, et al.. (2020). Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility. Journal of Medicinal Chemistry. 63(24). 15726–15751. 22 indexed citations
3.
Amado, Maite, Janet C. Reid, Alysha G. Elliott, et al.. (2019). An optimised Cu(0)-RDRP approach for the synthesis of lipidated oligomeric vinyl azlactone: toward a versatile antimicrobial materials screening platform. Journal of Materials Chemistry B. 7(43). 6796–6809. 12 indexed citations
4.
He, Yaowu, et al.. (2018). Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1. Biological Chemistry. 399(9). 1091–1097. 3 indexed citations
5.
Salla, Manohar, et al.. (2017). Synthesis of deuterium-labelled analogues of NLRP3 inflammasome inhibitor MCC950. Bioorganic & Medicinal Chemistry Letters. 28(4). 793–795. 6 indexed citations
6.
Reid, Janet C., Admire Matsika, Claire M. Davies, et al.. (2017). Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.. PubMed. 7(11). 2257–2274. 17 indexed citations
7.
Hill, James R., Rebecca C. Coll, Nancy Sue, et al.. (2017). Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors. ChemMedChem. 12(17). 1449–1457. 49 indexed citations
8.
Reid, Janet C., Nigel C. Bennett, Carson Stephens, et al.. (2016). In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B. QUT ePrints (Queensland University of Technology). 1 indexed citations
9.
Salla, Manohar, Mark S. Butler, Ruby Pelingon, et al.. (2016). Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950. ACS Medicinal Chemistry Letters. 7(12). 1034–1038. 40 indexed citations
10.
Reid, Janet C., Nigel C. Bennett, Carson Stephens, et al.. (2016). In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B. Biological Chemistry. 397(12). 1299–1305. 8 indexed citations
11.
He, Yaowu, Andreas Wortmann, Leslie Burke, et al.. (2010). Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKC?. QUT ePrints (Queensland University of Technology).
13.
Swedberg, Joakim E., Janet C. Reid, Carina Walpole, et al.. (2009). Substrate-Guided Design of a Potent and Selective Kallikrein-Related Peptidase Inhibitor for Kallikrein 4. Chemistry & Biology. 16(6). 633–643. 1 indexed citations
14.
Ramsay, A. J., Janet C. Reid, Mark N. Adams, et al.. (2008). Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biological Chemistry. 389(6). 653–668. 37 indexed citations
15.
Terregino, Calogero, et al.. (1997). Secondary Emergency Department Triage (Supertriage) and Trauma Team Activation. PubMed. 43(1). 61–64. 25 indexed citations
16.
Reid, Janet C. & J. D. Swales. (1994). Hypertension in Theory and Practice. Medical Entomology and Zoology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026